超声造影剂Sonazoid(示卓安)用于甲状腺癌淋巴结转移初步进展  

Preliminary application progresses of ultrasound contrast agents Sonazoid in lymph node metastasis of thyroid cancer

作　　者：贺丹阳 邓伟[1] 张英霞[1] HE Danyang;DENG Wei;ZHANG Yingxia(Department of Ultrasound Diagnosis,the Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China)

机构地区：[1]内蒙古医科大学附属医院超声诊断科,内蒙古呼和浩特010050

出　　处：《中国介入影像与治疗学》2024年第11期712-715,共4页Chinese Journal of Interventional Imaging and Therapy

摘　　要：颈部淋巴结转移(CLNM)是甲状腺癌复发的重要危险因素;超声为术前评估颈部淋巴结状态的影像学首选方法。利用超声造影剂可提升观察部位与周围组织的回声差异、反映局部微血流灌注,从而提高诊断准确率。近年于国内获批上市的超声造影剂Sonazoid(示卓安)具有良好的稳定性及独特的血管后期显影能力。本文就Sonazoid的物理特性及其在甲状腺癌CLNM中的初步应用进展进行综述。Cervical lymph node metastasis(CLNM)is an important risk factor for recurrence of thyroid cancer,and ultrasound is the first imaging method for preoperative assessing status of cervical lymph node.Ultrasound contrast agents can be used to enhance the echo difference between target site and surrounding tissue,reflect microvascular perfusion and improve diagnostic accuracy.As a new ultrasound contrast agent approved for sale in China in recent years,Sonazoid demonstrated good stability and unique ability of vascular late-phase imaging.The physical properties and preliminary application progresses of Sonazoid in CLNM of thyroid cancer were reviewed in this article.

关 键 词：甲状腺肿瘤 淋巴结转移 超声检查 造影剂 

分 类 号：R736.1[医药卫生—肿瘤] R445.1[医药卫生—临床医学]